Reading size

PACK IN HAND · ONE-PAGE CHECK

Medicine pack check sheet

Print this sheet or fill it in before speaking with a pharmacist or clinician. Copy only what is printed on the pack in hand. The published fields below are starting points from this record, not proof that your pack is the same product.

Published record starting point

Record display name
DULCOLAX PINK
Generic name / active ingredient
bisacodyl
Dosage-form class
Dosage form and presentation as documented in the linked primary label
Route
Oral
Record reviewed
2026-08-24

Copy from the pack in hand

Source-linked reading points

  • Check DULCOLAX PINK, bisacodyl, 5 mg per tablet, coated oral-tablet form, NDC 41167-0290-5, the 25-tablet blister-pack carton and target market together. 5 mg is the labelled strength for this exact tablet, not a web answer to anyone's tablet count.
  • The label says not to chew or crush the tablets and cautions against use within one hour after an antacid or milk. These are key reading points from the label for the actual product, not a website timetable, food rule or substitution plan for anyone.
  • The label directs readers with stomach pain, nausea or vomiting, a bowel-habit change lasting over two weeks, rectal bleeding, no bowel movement after use or a need for a laxative over one week to contact a clinician or pharmacist through the label. Do not turn these warnings into self-directed increase, continuation, stopping, combination or switching steps from a webpage.
  • The name, pink appearance, DL imprint or package image can only help locate a source; they cannot authenticate a product, establish current approval or decide individual suitability. With severe abdominal pain, fainting, persistent vomiting, bleeding or another acute problem, prioritise local emergency medical support.

Reviewed presentation examples — compare every field

  • Bisacodyl 5 mg per tablet; 25-tablet blister-pack cartonNDC 41167-0290-5

EDITORIAL RECORD

Who prepared and checked this page

Byline
OriginDrug Content Editorial
Review role
Public primary-source verification
Last reviewed
2026-08-24
Source record
2 clickable primary-source entry points are listed with this dossier.

The review role checks source traceability, stated market, document version and product-identity fields. It is not a claim of clinical licensure, prescribing authority or individual pharmacy service. Read the editorial policy.

Search records
Enlarged public-label image